Navigation Links
New diagnostic imaging for lung cancer could prevent unnecessary surgery
Date:9/25/2011

Amsterdam, The Netherlands: A new type of diagnostic imaging - which can better differentiate benign lung lesions from those which are cancerous - could be used to prevent unnecessary surgery by enabling more accurate diagnosis of the disease.

A study by Belgian researchers, which will be presented today (25 September 2011) at the European Respiratory Society's Annual Congress in Amsterdam, found that the new technique can more accurately determine whether people have the disease when compared with the current method of PET-CT scans.

PET-CT scans are currently used by a doctor to determine what stage the cancer is at and whether the detected lung lesions are cancerous. This test involves a CT scan taking pictures from around your body and a PET scan which uses a small amount of an injected radioactive drug to show uptake within structures in your body.

Whilst this is the current gold-standard for treatment, this new research has shown that a type of MRI scan, known as diffusion-weighted MRI, is more accurate. This technique measures water movement in the tissue of the lungs and can detect the structural changes that lung cancer causes, even in the early stages of the disease.

The new technique also has the advantage of being non-invasive and does not require any radiation exposure.

The research analysed 50 people who were due to be operated on and had been diagnosed with lung cancer or suspected lung cancer assessed by PET-CT scan. One day before their operation, the same group also underwent a diffusion-weighted MRI scan.

The results showed that with PET-CT scans, 33 patients were diagnosed correctly, 7 incorrectly and 10 were undetermined. With diffusion-weighted MRI scans, 45 patients were diagnosed correctly and 5 incorrectly. The 10 undetermined cases with PET-CT were correctly diagnosed using diffusion-weighted MRI scan.

Dr Johan Coolen, from University Hospitals Leuven in Belgium, said: "Our study has shown that diffusion-weighted MRI scans could become an appropriate diagnostic instrument for preoperative lung cancer patients in the near future because they have a high accuracy for differentiating benign from malignant lung lesions.

"PET/CT scans can wrongly diagnose cancer as they can misinterpret inflammation in the lungs as a malignant lesion. Especially in these inflammatory lesions, diffusion weighted MR is more accurate which could help avoid unnecessary surgical procedures for those people without malignant disease. In addition, it could help to classify patients with lung cancer to enable doctors to provide the most effective therapeutic procedures."

Professor Marc Decramer, President of the European Respiratory Society, said: "It is crucial that we continue to evaluate new diagnostic technologies and look at incorporating these into our management of lung cancer. A key recommendation of the European Respiratory Roadmap, which has been launched this week to steer the future of respiratory medicine, is to focus on effective screening processes. In a bid to improve patient care, the roadmap also suggests that personalised targeted medicine will improve a patient's quality of life. With the development and evaluation of new technologies such as the diffusion-weighted MRI scan, we can work towards achieving these goals."


'/>"/>

Contact: Lauren Anderson
lauren.anderson@europeanlung.org
31-610-860-810
European Lung Foundation
Source:Eurekalert

Related medicine news :

1. New Diagnostic Guidelines for Mental Illnesses Proposed
2. MRI: Non-invasive diagnostic tool for diagnosing testicular cancer
3. Damaged protein identified as early diagnostic biomarker for Alzheimers disease in healthy adults
4. Health Diagnostic Laboratory Inc. (HDL, Inc.) Launches Community Initiative, It Starts with the Heart
5. Ziosoft Expands PhyzAiodynamic Diagnostic Solutions into Greek Healthcare Market
6. Use and costs of diagnostic imaging increasing for patients with cancer
7. New Diagnostic Testing Company, Blue Ocean Biomedical, Specializes In Automated, Load & Go Cell Analysis Systems For Immune Monitoring
8. ELLKAY Introduces Revolutionary Live Insurance Mapping Solution for Diagnostic Laboratories
9. More Than Half of Pediatricians Make Diagnostic Errors: Survey
10. Diagnostic blood test can identify rare lung disease
11. Flagship Biosciences Partners with a Leading IHC CLIA Laboratory for Companion Diagnostics Service
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... 21, 2017 , ... Sharon Kleyne is proud of the ... research center at Bio-Logic Aqua Research® Water Life Science®, has been released in ... sufferers of blindness. “We think that Nature’s Tears® EyeMist® will contribute to eliminating ...
(Date:7/21/2017)... ... July 21, 2017 , ... ... ligament (ACL) offer patients improved quality of life five years after injury, according ... Annual Meeting in Toronto, Ontario, Canada. The study followed patients for five ...
(Date:7/20/2017)... ... July 20, 2017 , ... ChenMed , a ... joined JenCare Senior Medical Center as Richmond Chief Medical Officer. Dr. ... Medicine, and Associate Chief Medical Officer of Ambulatory Services for the UVA Health System, ...
(Date:7/20/2017)... , ... July 20, 2017 , ... ... firm headquartered in Houston, is pleased to announce their expansion to the Midwest ... housing experience, directors Alysse Hollis and Ronald Bell, and of counsels, John Peck ...
(Date:7/20/2017)... ... July 20, 2017 , ... Team Type 1 Foundation, a nonprofit organization pursuing ... by diabetes, is teaming up with a Microsoft Corp. employee-led hackathon team for the ... 24th. , “Team Type 1’s mission overlaps seamlessly with Microsoft’s mission to empower ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... Ill. , July 11, 2017  Sysmex ... and urinalysis diagnostic testing equipment as well as ... innovation: a way to make quality assurance easier ... processes. "Sysmex is well known for the innovation ... Quality Monitor elevates quality assurance processes to ...
(Date:7/10/2017)... COLUMBIA, S.C. , July 10, 2017 /PRNewswire/ ... product purchasing and patient support services organization serving ... announced today the launch of four significant, value-added ... into market insights, better manage reimbursement and improve ... Ig and factor therapies. ...
(Date:7/5/2017)... JERUSALEM , July 5, 2017 ... www.oramed.com ), a clinical-stage pharmaceutical company ... today that it has received approval from the Israel Securities ... Stock Exchange (TASE). Oramed common stock will commence trading on ... Based on the current market capitalization of the Company, it ...
Breaking Medicine Technology: